Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Guided Therapeutics Inc (GTHP)

Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Guided Therapeutics Inc 5835 PEACHTREE CORNERS EAST SUITE B PEACHTREE CORNERS GA 30092 USA

www.guidedinc.com P: 770-242-8723

Description:

GUIDED THERAPEUTICS, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are available immediately. GT also owns technology for measuring substances in interstitial fluid, a secondary circulatory system in the body that surrounds the cells.

Key Statistics

Overview:

Market Capitalization, $K 6,077
Enterprise Value, $K 9,057
Shares Outstanding, K 55,756
Annual Sales, $ 100 K
Annual Net Income, $ -3,490 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -390 K
EBIT, $ -3,460 K
EBITDA, $ -3,240 K
60-Month Beta 0.34
% of Insider Shareholders 66.83%
% of Institutional Shareholders 9.69%
Float, K 18,494
% Float 33.17%
Short Volume Ratio 1.00

Growth:

1-Year Return -56.45%
3-Year Return -85.94%
5-Year Return -36.26%
5-Year Revenue Growth 66.67%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 03/28/24
Latest Earnings Date 04/01/24
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr 100.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-800 on 03/29/19

GTHP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -158.84%
Profit Margin % -3,490.00%
Debt/Equity -0.14
Price/Sales 49.67
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.07
Interest Coverage -11.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar